Próby wykorzystania szczepionek genetycznych przeciwko helmintom

• Authors: Luiza Jedlina-Panasiuk

Title variants

EN

Trials at application of genetic vaccines against helminths

• Languages of publication: PL EN

Abstracts

EN

At present cloning technologies are being rapidly developed leading to creation of new vaccines, especially based on DNA or recombinant proteins. DNA vaccination appears to offer better prospects for the development of multivalent vaccines that will effectively activate both the humoral and cellular mechanisms of the immune system. Currently the possibility of DNA vaccination against such important parasitic diseases like malaria, leishmaniosis, toxoplasmosis, cryptosporidiosis, schistosomosis, fasciolosis is being widely explored. However, the outcome of vaccination depends vastly on vaccine formulations, dose and route of vaccine delivery, and the species or even strain against which the host is vaccinated. To overcome these problems much research is still needed, specifically focused on cloning and testing of new DNA target sequences.

• Journal: Kosmos
• Year: 2005
• Volume: 54
• Issue: 1
• Pages: 123-130

Dates

published

2005

Contributors

author

Luiza Jedlina-Panasiuk

• Instytut Parazytologii im. W. Stefańskiego PAN, Twarda 51/55, 00-818 Warszawa, Polska

References

• COSTA F., FRANCHIN G., PEREIRA-CHOCCOLA V. L., RIBEIARO M., SCHEKMAN S., RODRIGUES M. M., 1998. Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma crusi infection in mice. Vaccine 16, 768-774.
• COWDERY J. S., CHACE J. C., YI A., KRIEG A. M., 1996. Bacterial DNA induces NK cells to produce IFN-gamma_in vivo and increases the toxicity of lipopolysaccharides. J. Immunol. 156, 4570-4575.
• DALTON J. P., MCGONILE S., ROLPH T. P., ANDREWS S. J., 1996. Induction of protective immunity in cattle against infection with Fasciola hepatica by vaccination with cathepsin L proteinases and with hemoglobin. Infect. Immunol. 64, 5066-5074.
• DANKO I., WOLFF J. A., 1994. Direct gene transfer into muscle. Vaccine 12, S1499-1502.
• DAVIS H. L., MICHEL M. L., WHALEN R. G. 1995. Use of plasmid DNA for direct gene transfer and immunization. Ann. NY Acad. Sci. 772, 21-29.
• DAVIS H. L., BRAZOLOT MILLAN C. L., MANCINI M., MCCLUSKIE M. J., HADCHOUEL M., COMANITA L., TIOLLAIS P., WHALEN R. G., MICHEL M. L., 1997. DNA-based immunization against hepatitis B surface antigen (HBsAg) in normal and HBsAg-transgenic mice. Vaccine 15, 849-852.
• DREW D. R., LIGHTOWLERS M., STRUGNELL R. A., 2000. Humoral immune responses to DNA vaccinesexpressingsecreted, membrane bound and non-secreted forms of the Taenia ovis 45W antigen. Vaccine 18, 2522-2532.
• ERTL H. C. J., XIANG Z., 1996 Novel vaccine approaches. J. Immunol. 156, 3579-3582.
• HALPERN, M. D., KDER, R. J., PISETSKY, D. S., 1996. Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-gamma. Cell Immunol. 167, 72-78.
• HARN D. A., REYNOLDS S. R., CHIKUNGUWO S., DISSAYANKE S., SKELLY P., SHOEMAKER C., OKANO M., 1998. Peptide and DNA vaccines for schistosomiasis, and discovery of a novel adjuvant that promotes antibody responses. Parasitol. Int. 47 (Suppl.), 14.
• HOFFMAN S. L., SEDEGAH M., HEDSTROM R. C., 1994. Protection against malaria by immunization with a Plasmodium yoelli circumsporozoite protein nucleic acid vaccine. Vaccine 12, 1529-1533.
• HOFFMAN S. L., DOOLAN D. L., SEDEGAH M., AGUIAR J. C., WANG R., MALIK A., GRAMZINSKI R. A., WEISS W. R., HOBART P., NORMAN J. A., MARGALITH M., HEDSTROM R. C., 1997. Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use. Vaccine 15, 842-845.
• JAKÓBISIAK M., 2002. Immunologia. Wydanie Naukowe PWN, Warszawa.
• KLINMAN D. M., YI A. K., BEAUCAGE S. L., CONOVER J., KRIEG A. M., 1996. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon-gamma. PNAS 93, 2879-2883.
• KOFTA W., MIWSZCZANEK J., PLUCIENNICZAK G.,WEDRYCHOWICZ H., 2000. SuccesfulDNAvaccination of rats against fasciolosis. Vaccine 18, 2985-2990.
• KOFTA W., WĘDRYCHOWICZ H., 2001. c-DNA vaccination against parasitic infections: advantages and disadvantages. Vet. Parasitol. 94, 243-247.
• LE T. P., COONAN K. M., HEDSTROM R. C., CHAROENVIT Y., SEDEGAH M., EPSTEIN J. E., KUMAR S., WANG R. B., DOOLAN D. L., MAGUIRE J. D., PARKER S. E., HOBART P., NORMAN J., HOFFMAN S. L., 2000. Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers. Vaccine 18, 1893-1901.
• MEEUSEN E. N. T., BRANDON M. R., 1994. The use of antibody-secreting cell probes reveal tissue-restricted immune responses during infection. Eur. J. Immunol.24, 469-474.
• MULCAHY G., O'CONNOR F., CLERY D., HOGAN S. F., DOWD A. J., ANDREWS S. J., DALTON J. P., 1999. Immune responses of cattle to experimental an-ti-Fasciola hepatica vaccines. Res. Vet. Sci. 67, 27-33.
• OCKENHOUSE C. F., SUN P., LANAR D. E., WELLDE B. T., HALL B. T., KESTER K., STOUTE J. A., MAGILL A., KRZYCH U., FARLEY L.,WIRTZ R. A., SADOFF J. C., KASLOW D. C., KUMAR S., PRESTON CHURCH L. W., CRUTHER J. M.,WIZEL B., HOFFMAN S., LALVANI A., HILL A. V. S., TINE J. A., GUITO K. P., DE TAISNE C., ANDERS R., HORII T., PAOLETTI E., ROPLEY BALLOU W., 1998. Phase I/Iia safety, immunogenicity, and efficacy trial on NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. J. Inf. Dis. 177, 1664-1673.
• OLDHAM G., 1983. Protection against Fasciola hepatica in rats with adult fluke antigen in Freund's adjuvant: influence of antigen batch, antigen dose and number of sensitising injections. Res. Vet. Sci. 34, 240-244.
• RAZ E., TIGHE H., SATO Y., CORR M., DUDLER J. A., ROMAN M., SWAIN S. L., SPIEGELBERG H. L., CARSON D. A., 1996. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. PNAS 93, 5141-5145.
• ROSAS G., CRUZ-REVILLA C., FRAGOSO G., LOPEZ-CASILLAS F., PEREZ A., BONILLA M. A., ROSALES R., SCIUTTO E., 1998. Taenia crassiceps cysticercosis: humoral immune response and protection elicited by DNA immunization. J. Parasitol. 84, 516-523.
• ROTHEL J. S., WATERKEYN J. G., STRUGNELL R. A., WOOD P. R., SEOW H. F., VADOLAS J., LIGHTOWLERS M. W., 1997. Nucleic acid vaccination of sheep: use in combination with a conventional adjuvanted vaccine against Taenia ovis. Immunol. Cell Biol. 75, 41-46.
• SIEGRIST C. A., 1997 Potential advantages and risks of nucleic acid vaccines for infant immunization. Vaccine 15, 798-800.
• SMOOKER P. M., STEEPER K. R., DREW D. R., STRUGNELL R. A., SPITHILL T. W., 2001. Humoral responses in mice following vaccination with DNA encoding glutathione-S-transferase of Fasciola hepatica. Parasite Immunol. 21, 357-364.
• SPITHILL T. W., DALTON J. P., 1998. Progress in development of liver fluke vaccines. Parasitol. Today 14, 224-228.
• TASCON R. E., COLSTON M. J., RAGNO S., 1996. Vaccination against tuberculosis by DNA injection. Nat. Med. 2, 888-892.
• TINE J. A., LANAR D. E., SMITH D. M., WELLDE B. T., SCHULTHEISS P., WARE L. A., KAUFFMAN E. B., WIRTZ R. A., DE TAISNE C., HUI G .S. N., CHANG S. P., CHURCH P., HOLLINGDALE M. R., KASLOW D. C., HOFFMAN S., GUITO K. P., RIPLEY BALLOU W., SADOFF J. C., PAOLETTI E., 1996. NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. Inf. Immunol. 64, 3833-3844.
• TORT J., BRIDLEY P. J., KNOX D., WOLFE K. H., DALTON J. P., 1999. Proteinases and associated genes of parasitic helmints. Adv. Parasitol. 43, 161-265.
• TSUJI N., SUZUKI K., KASUGA-AOKI H., ISOBE T., ARAKAWA T., MATSUMOTO Y., 2003. Mice intranasally immunized with a recombinant 16-kilodalton antigen from roundworm Ascaris parasites are protected against larval migration of Ascaris suum. Inf. Immunity 71, 5314-5323.
• WĘDRYCHOWICZ H., KLOCKIEWICZ M., 1994. Protective and diagnostic molecules of Fasciola hepatica. Acta Parasitol. 39, 173-178.
• WĘDRYCHOWICZ H., SZYMAŃSKI P., JEDLINA-PANASIUK L, BIEŃKOWSKA-SZEWCZYK K., 2002. Humoral immune response of rats vaccinated with cDNA or protein form of glutathione-S-transferase of Fasciola hepatica to infection with metacercariae of the fluke. Helminthologia 39, 127-133.
• WĘDRYCHOWICZ H., LAMPARSKA M., KĘSIK M., KOTOMSKI G., MIESZCZANEK J., JEDLINA-PANASIUK L., PLUCIENNICZAK A., 2003. The immune response of rats to vaccination with the cDNA or protein forms of the cysteine proteinase of Fasciola hepatica. Veterinary Immunol. Immunopathol. 94, 83-93.
• WĘDRYCHOWICZ H., WIŚNIEWSKI M., 2003. Progress in development of vaccines against most important gastrointestinal helminth parasites of humans and animals. Acta Parasitol. 48, 238-245.
• Xu D., Liew F. Y., 1994. Genetic vaccination against leishmaniasis. Vaccine 12, 1534-1536.
• YAG W., WAINE G. J., MCMANUS D. P., 1995. Antibodies to Schistosoma japonicum (asian bloodfluke) paramyosin induced by nucleic acid vaccination. Bioch. Biophis. Res. of Comm. 212, 1029-1039.